 |
|
Home | Maxim Group Gives Boston Scientific (NYSE: BSX) a “Sell” Rating |
 |
Maxim Group Gives Boston Scientific (NYSE: BSX) a “Sell” Rating
|
 |
- October 22, 2010
-
Maxim Group equities research analysts gave shares of Boston Scientific (NYSE: BSX) a new “sell” rating in a research note to investors on Tuesday, with a price target of $4.50 saying that the company is facing multiple execution challenges. Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in [...]This article (Maxim Group Gives Boston Scientific (NYSE: BSX) a “Sell” Rating) was originally developed by and is property of American Banking News. Checkout American Banking News for up-to-date banking news and peer to peer lending news.
- Read more at:http://feedproxy.google.com/~r/AmericanBankingNews/~3/OiiZwDGGvNY/
|
 |
|
 |
|
 |
